Plant sterol and stanol intake in Finland: a comparison between users and nonusers of plant sterol- and plant stanol-enriched foods

Marttinen, Maija; Kosola, Mikko; M-L, Ovaskainen; Mutanen, Marja; Männistö, Satu

doi:10.1038/ejcn.2014.3

Cited by 4 publications

(2 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The stanols can be produced by the hydrogenation of plant sterols [31]. In Finland, as an example, the natural dietary intake of phytosterols is about 300 mg/day [32,33]. Plant stanols, again, represent a very low share of the phytosterols; their daily natural intake is only about 20 mg [32,33].…”

Section: Cholesterol-lowering Diet Compared With Dietary Interventmentioning

confidence: 99%

Decreasing the Cholesterol Burden in Heterozygous Familial Hypercholesterolemia Children by Dietary Plant Stanol Esters

Vuorio

Kovanen

2018

Nutrients

View full text Add to dashboard Cite

This review covers the current knowledge about plant stanol esters as a dietary treatment option for heterozygous familial hypercholesterolemia (he-FH) children. The current estimation of the prevalence of he-FH is about one out of 200–250 persons. In this autosomal dominant disease, the concentration of plasma low-density lipoprotein cholesterol (LDL-C) is strongly elevated since birth. Quantitative coronary angiography among he-FH patients has revealed that stenosing atherosclerotic plaques start to develop in he-FH males in their twenties and in he-FH females in their thirties, and that the magnitude of the plaque burden predicts future coronary events. The cumulative exposure of coronary arteries to the lifelong LDL-C elevation can be estimated by calculating the LDL-C burden (LDL-C level × years), and it can also be used to demonstrate the usefulness of dietary stanol ester treatment. Thus, when compared with untreated he-FH patients, the LDL-C burden of using statin from the age of 10 is 15% less, and if he-FH patients starts to use dietary stanol from six years onwards and a combination of statin and dietary stanol from 10 years onwards, the LDL-C burden is 21% less compared to non-treated he-FH patients. We consider dietary stanol treatment of he-FH children as a part of the LDL-C-lowering treatment package as safe and cost-effective, and particularly applicable for the family-centered care of the entire he-FH families.

show abstract

Section: Cholesterol-lowering Diet Compared With Dietary Interventmentioning

confidence: 99%

Decreasing the Cholesterol Burden in Heterozygous Familial Hypercholesterolemia Children by Dietary Plant Stanol Esters

Vuorio

Kovanen

2018

Nutrients

View full text Add to dashboard Cite

show abstract

“…The same concerns plant sterols. For example, a Finnish study showed that more than half of the users of foods with added plant stanol or plant sterol ester did not reach the recommended daily intake [ 44 ]. Another example is a survey on consumer purchase behaviour which included 91,000 households in the Netherlands, Belgium, United Kingdom, France, and Germany [ 45 ].…”

Section: Optimal Use Of Plant Stanol Estermentioning

confidence: 99%

Optimal Use of Plant Stanol Ester in the Management of Hypercholesterolemia

et al. 2015

View full text Add to dashboard Cite

Plant stanol ester is a natural compound which is used as a cholesterol-lowering ingredient in functional foods and food supplements. The safety and efficacy of plant stanol ester have been confirmed in more than 70 published clinical studies and the ingredient is a well-established and widely recommended dietary measure to reduce serum cholesterol. Daily intake of 2 g plant stanols as plant stanol ester lowers LDL-cholesterol by 10%, on average. In Europe, foods with added plant stanol ester have been on the market for 20 years, and today such products are also available in many Asian and American countries. Despite the well-documented efficacy, the full potential in cholesterol reduction may not be reached if plant stanol ester is not used according to recommendations. This review therefore concentrates on the optimal use of plant stanol ester as part of dietary management of hypercholesterolemia. For optimal cholesterol lowering aiming at a lower risk of cardiovascular disease, plant stanol ester should be used daily, in sufficient amounts, with a meal and in combination with other recommended dietary changes.

show abstract

Consumer evaluation, use and health relevance of health claims in the European Union

Hung

Verbeke

2019

Food Quality and Preference

View full text Add to dashboard Cite

Plant sterol and stanol intake in Finland: a comparison between users and nonusers of plant sterol- and plant stanol-enriched foods

Abstract: The intake of PS can reach several grams in a subgroup of subjects consuming PS-enriched foods. The manufacturers' recommendations on PS-enriched food consumption are not consistently followed, and customer guidance needs to be improved.

Cited by 4 publications

References 24 publications

Decreasing the Cholesterol Burden in Heterozygous Familial Hypercholesterolemia Children by Dietary Plant Stanol Esters

Decreasing the Cholesterol Burden in Heterozygous Familial Hypercholesterolemia Children by Dietary Plant Stanol Esters

Optimal Use of Plant Stanol Ester in the Management of Hypercholesterolemia

Consumer evaluation, use and health relevance of health claims in the European Union

Contact Info

Product

Resources

About